Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04758949
Title FL-101 in Surgically Resectable Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Flame Biosciences
Indications

lung squamous cell carcinoma

lung non-squamous non-small cell carcinoma

Therapies

Nivolumab

FL-101 + Nivolumab

FL-101

Age Groups: senior | adult
Covered Countries USA | CAN

Additional content available in CKB BOOST